Y Hattori1, S Hattori, N Sato, K Kasai. 1. Department of Endocrinology, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.
Abstract
OBJECTIVE: Vascular smooth muscle cell (VSMC) dysfunction plays a role in diabetic macrovasculopathy. This dysfunction may be caused or exacerbated by expression of many of genes potently activated by the transcriptional factor nuclear factor kappaB (NF-kappaB). We have examined whether culture of VSMCs under high glucose conditions to stimulate the diabetic state can lead to the activation of NF-kappaB. METHODS: NF-kappaB activation was assessed in VSMCs stably transfected with a cis-reporter plasmid containing the NF-kappaB binding sites. RESULTS: Within 3-h incubation, high glucose (27.5 or 55 mmol/l) alone induced an increase in NF-kappaB activity in VSMCs; this increase was mimicked by mannitol given to deliver the same osmolar stress to the cells. High glucose or mannitol also enhanced TNFalpha-stimulated NF-kappaB activity. Incubation with high glucose for 48 h followed by stimulation with TNFalpha led to a marked potentiation of NF-kappaB activation compared with normoglycemic (5.5 mmol/l) VSMCs exposed to TNFalpha, while mannitol attenuated this effect. A 48-h incubation with high glucose substantially reduced glutathione (GSH) levels compared with normoglycemic VSMCs, whereas mannitol significantly increased GSH levels. An antioxidant N-acetyl-L-cysteine and a selective protein kinase C (PKC) inhibitor GF109203X significantly suppressed the TNFalpha-induced NF-kappaB activation, and abrogated potentiation of TNFalpha-induced NF-kappaB activity caused by high glucose (27.5 mmol/l). CONCLUSION: These results suggest that acutely high glucose causes alterations in osmolarity leading to activation of NF-kappaB, but that exposure to high glucose for more prolonged times causes changes in antioxidant defences and activation of PKC, which potentiates cytokine activation of NF-kappaB. Further definition of these pathways will help to delineate important signals mediating the aberrant behavior of VSMCs under hyperglycemic/diabetic conditions.
OBJECTIVE: Vascular smooth muscle cell (VSMC) dysfunction plays a role in diabetic macrovasculopathy. This dysfunction may be caused or exacerbated by expression of many of genes potently activated by the transcriptional factor nuclear factor kappaB (NF-kappaB). We have examined whether culture of VSMCs under high glucose conditions to stimulate the diabetic state can lead to the activation of NF-kappaB. METHODS:NF-kappaB activation was assessed in VSMCs stably transfected with a cis-reporter plasmid containing the NF-kappaB binding sites. RESULTS: Within 3-h incubation, high glucose (27.5 or 55 mmol/l) alone induced an increase in NF-kappaB activity in VSMCs; this increase was mimicked by mannitol given to deliver the same osmolar stress to the cells. High glucose or mannitol also enhanced TNFalpha-stimulated NF-kappaB activity. Incubation with high glucose for 48 h followed by stimulation with TNFalpha led to a marked potentiation of NF-kappaB activation compared with normoglycemic (5.5 mmol/l) VSMCs exposed to TNFalpha, while mannitol attenuated this effect. A 48-h incubation with high glucose substantially reduced glutathione (GSH) levels compared with normoglycemic VSMCs, whereas mannitol significantly increased GSH levels. An antioxidant N-acetyl-L-cysteine and a selective protein kinase C (PKC) inhibitor GF109203X significantly suppressed the TNFalpha-induced NF-kappaB activation, and abrogated potentiation of TNFalpha-induced NF-kappaB activity caused by high glucose (27.5 mmol/l). CONCLUSION: These results suggest that acutely high glucose causes alterations in osmolarity leading to activation of NF-kappaB, but that exposure to high glucose for more prolonged times causes changes in antioxidant defences and activation of PKC, which potentiates cytokine activation of NF-kappaB. Further definition of these pathways will help to delineate important signals mediating the aberrant behavior of VSMCs under hyperglycemic/diabetic conditions.
Authors: Pankaj Arora; Connie Wu; Tariq Hamid; Garima Arora; Obiajulu Agha; Kaitlin Allen; Robert E T Tainsh; Dongjian Hu; Romy A Ryan; Ibrahim J Domian; Emmanuel S Buys; Donald B Bloch; Sumanth D Prabhu; Kenneth D Bloch; Christopher Newton-Cheh; Thomas J Wang Journal: J Am Coll Cardiol Date: 2016-02-23 Impact factor: 24.094
Authors: Marissa de Mos; André Laferrière; Magali Millecamps; Mercedes Pilkington; Miriam C J M Sturkenboom; Frank J P M Huygen; Terence J Coderre Journal: J Pain Date: 2009-11 Impact factor: 5.820